CNS Pharmaceuticals, Inc. (CNSP)
5.13
+0.35
(+7.32%)
USD |
NASDAQ |
May 20, 16:00
4.98
-0.15
(-2.92%)
After-Hours: 07:05
CNS Pharmaceuticals Free Cash Flow : -15.24M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| Merck & Co., Inc. | 14.12B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.649M |
| Cash from Investing (Quarterly) | -0.0062M |
| Cash from Financing (Quarterly) | 0.4047M |
| Free Cash Flow Per Share (Quarterly) | -6.884 |
| Free Cash Flow to Equity (Quarterly) | -4.559M |
| Free Cash Flow to Firm (Quarterly) | -4.649M |
| Free Cash Flow Yield | -542.2% |